Exhausted or Unlicensed: Can Field-of-Use Restrictions in Biotech License Agreements Still Prevent Off-Label Use Promotion After Quanta Computer?
The University of New Hampshire Law Review
Part of the Pharmaceutics and Drug Design Commons
Part of the Pharmaceutics and Drug Design Commons